Biopsies: next-generation biospecimens for tailoring therapy (Q38116896)

29 August 2017

title

Biopsies: next-generation biospecimens for tailoring therapy (English)

1 reference

29 August 2017

0 references

5

Sabine Tejpar

0 references

author name string

Mark Basik

1

1 reference

29 August 2017

Adriana Aguilar-Mahecha

2

1 reference

29 August 2017

Caroline Rousseau

3

1 reference

29 August 2017

Zuanel Diaz

4

1 reference

29 August 2017

Alan Spatz

6

1 reference

29 August 2017

Celia M T Greenwood

7

1 reference

29 August 2017

Gerald Batist

8

1 reference

29 August 2017

language of work or name

English

0 references

publication date

25 June 2013

1 reference

Nature Reviews Clinical Oncology

29 August 2017

published in

1 reference

29 August 2017

volume

10

1 reference

29 August 2017

issue

8

1 reference

29 August 2017

page(s)

437-450

1 reference

Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Personalized oncology through integrative high-throughput sequencing: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Next-generation sequencing: ready for the clinics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

International network of cancer genome projects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Comprehensive molecular characterization of human colon and rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Comprehensive genomic characterization of squamous cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Genome remodelling in a basal-like breast cancer metastasis and xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Whole genome sequencing of matched primary and metastatic acral melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Cancer: Genomics of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Circulating tumor cells as therapy-related biomarkers in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Use of research biopsies in clinical trials: are risks and benefits adequately discussed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Trends in the use and role of biomarkers in phase I oncology trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Gene expression-based prognostic signatures in lung cancer: ready for clinical use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Pharmacogenetic analysis of BR.21, a placebo-controlled randomized phase III clinical trial of erlotinib in advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Role of randomized phase III trials in an era of effective targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Heterogeneity of KRAS status may explain the subset of discordant KRAS status between primary and metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

The BATTLE trial: personalizing therapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

The genetic basis for cancer treatment decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Feasibility and safety of sequential research-related tumor core biopsies in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

The ethical use of mandatory research biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Guidelines on the use of liver biopsy in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Tumour seeding following percutaneous needle biopsy: the real story!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Managing incidental findings and research results in genomic research involving biobanks and archived data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Disclosure of individual genetic data to research participants: the debate reconsidered

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Identifying personal genomes by surname inference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Global requirements for DNA sample collections: results of a survey of 204 ethics committees in 40 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Heterogeneity of kinase inhibitor resistance mechanisms in GIST

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Genetic clonal diversity predicts progression to esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Characterization of bone metastases from rapid autopsies of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

A novel flexible cryoprobe for EUS-guided pancreatic biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Cryoprobe biopsy increases the diagnostic yield in endobronchial tumor lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Effect of fixatives and tissue processing on the content and integrity of nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Advancing formaldehyde cross-linking towards quantitative proteomic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

mRNA transcript quantification in archival samples using multiplexed, color-coded probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter Assay System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Deep clonal profiling of formalin fixed paraffin embedded clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Preservation of RNA for functional genomic studies: a multidisciplinary tumor bank protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Prognostic gene expression signatures can be measured in tissues collected in RNAlater preservative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Ultradense array CGH and discovery of micro-copy number alterations and gene fusions in the cancer genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Will PAXgene substitute formalin? A morphological and molecular comparative study using a new fixative system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Histological assessment of PAXgene tissue fixation and stabilization reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Non-formalin fixative versus formalin-fixed tissue: a comparison of histology and RNA quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Biobanking of fresh frozen tissue from clinical surgical specimens: transport logistics, sample selection, and histologic characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Laser capture microdissection for protein and NanoString RNA analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Whole genome analysis for liver metastasis gene signatures in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Computational dissection of tissue contamination for identification of colon cancer-specific expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Effective DNA/RNA co-extraction for analysis of microRNAs, mRNAs, and genomic DNA from formalin-fixed paraffin-embedded specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Next-generation sequencing of miRNAs with Roche 454 GS-FLX technology: steps for a successful application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

International approaches to advancing biospecimen science

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

SPIDIA-RNA: first external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

The NCI Biospecimen Research Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

The effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Drug development: Raise standards for preclinical cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Sources of bias in specimens for research about molecular markers for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Assessing the need for a standardized cancer HUman Biobank (caHUB): findings from a national survey with cancer researchers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Standard preanalytical coding for biospecimens: defining the sample PREanalytical code

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

RNA quality in frozen breast cancer samples and the influence on gene expression analysis--a comparison of three evaluation methods using microcapillary electrophoresis traces

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Leveraging a clinical research information system to assist biospecimen data and workflow management: a hybrid approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

The UCSC Cancer Genomics Browser: update 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Visualizing multidimensional cancer genomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Biorepositories: Building better biobanks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Certification for biobanks: the program developed by the Canadian Tumour Repository Network (CTRNet).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Toward a roadmap in global biobanking for health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Implementing personalized medicine in a cancer center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

The life history of 21 breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

CTCs in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Ethnic differences in response to epidermal growth factor receptor tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Biopsy of liver metastasis for women with breast cancer: Impact on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Biospecimen reporting for improved study quality (BRISQ)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their Decision

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Testing for discordance at metastatic relapse: does it matter?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Safety and efficacy of sonographically guided random core biopsy for diffuse liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

The importance of experience in percutaneous liver biopsies guided with ultrasonography: a lesion-focused approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Quality really matters: the need to improve specimen quality in biomedical research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Protocol for the quantitative assessment of DNA concentration and damage (fragmentation and nicks)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Evolution and dynamics of pancreatic cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.101

Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23799370

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23799370

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23799370

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2013.101

1 reference

29 August 2017

1 reference